Zontivity (voraxapar) is a new type of anti-platelet medication for people who have had a heart attack, or who have reduced blood flow in their legs. It is used to reduce the risk of heart attack, stroke, cardiovascular death, and the need for procedures to restore blood flow to the heart. It was approved by the FDA in May 2014, and will be available from manufacturer Merck later this year.
When will Zontivity be available?
According to the manufacturer the anticipated availability date for this medication is the third quarter of 2014. See More